Chlorophyllipt® (Chlorophyllipt®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbsplozenges
Composition:For one tablet:

Active ingredient:

Chlorophyllipt (Eucalyptus leaf extract)

The extract is thick in terms of dry matter with antibacterial

activity in a concentration of 12.5 μg per ml of medium

0.025 g

Excipients:

Sugar (sucrose)

0.617 g

Microcrystalline cellulose

0.120 g

Citric acid monohydrate

0.030 g

Calcium stearate

0.008 g
Description:

Tablets are flat-cylindrical, with a facet and a risk, from light green to green with lighter and darker patches, with a characteristic odor.

Pharmacotherapeutic group:antimicrobial agent of plant origin
ATX: & nbsp
  • Other antimicrobials
    • Pharmacodynamics:

    It has antibacterial (bacteriostatic and bactericidal) action, especially for staphylococci, including antibiotic-resistant strains. Has anti-inflammatory effect.

    Pharmacokinetics:

    No data available.

    Indications:

    In the complex therapy of diseases of the upper respiratory tract (tonsillitis, pharyngitis, laryngitis).

    Contraindications:

    Hypersensitivity to the components of the drug, congenital intolerance to fructose, glucose-galactose malabsorption, sugar / isomaltase deficiency, age to 18 years.

    Carefully:Patients with diabetes mellitus and people on a diet with a reduced carbohydrate content.
    Pregnancy and lactation:

    It is not recommended to use during pregnancy and during breastfeeding due to the lack of special studies.

    Dosing and Administration:

    Locally.

    1 tablet 5 times a day 30-40 minutes after eating. The maximum daily dose is 5 tablets. Tablets should be resorbed in the mouth until completely dissolved, without chewing.

    Duration of treatment is 7 days.

    Side effects:

    Allergic reactions are possible, a local irritant effect on the mucous membrane of the oral cavity.

    If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, inform the doctor about it.

    Overdose:

    Cases of chlorophyllipt overdose in topical application have not been recorded to date.

    Interaction:

    Not described.

    Special instructions:

    Before starting treatment, it is necessary to make a test for the patient's sensitivity to the drug. If there are no allergic reactions after 6-8 hours after taking one pill, you can start the course treatment.

    To avoid the local irritant effect of the drug on the oral mucosa, do not keep the tablet under the tongue or behind your cheek, and it is recommended to actively dissolve it in the oral cavity (no more than 30 minutes).

    Patients with diabetes should take into account that one tablet contains 0.617 g of carbohydrates (0.051 XE).

    Effect on the ability to drive transp. cf. and fur:The use of the drug does not affect the performance of potentially hazardous activities requiring increased concentration of attention and speed of psychomotor reactions.
    Form release / dosage:Tablets for resorption, 25 mg.
    Packaging:

    10 tablets per contour cell pack.

    2, 3 or 5 contour mesh packages together with the instruction for use are placed in a pack of cardboard.

    Storage conditions:

    In a dry, the dark place at a temperature of no higher than 20 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-002400
    Date of registration:17.03.2014
    Date of cancellation:2019-03-17
    The owner of the registration certificate:VIFITEH, CJSC VIFITEH, CJSC Russia
    Manufacturer: & nbsp
    Representation: & nbspVIFITEH, CJSCVIFITEH, CJSC
    Information update date: & nbsp31.01.2016
    Illustrated instructions
      Instructions
      Up